PapersFlow Research Brief
Economic and Financial Impacts of Cancer
Research Guide
What is Economic and Financial Impacts of Cancer?
Economic and Financial Impacts of Cancer refers to the economic burden and financial consequences of cancer treatment, including financial toxicity, out-of-pocket costs, healthcare expenditure, cost communication, drug pricing, productivity costs, and financial hardship for patients and healthcare systems.
This field encompasses 37,112 works analyzing the costs associated with cancer care. Studies address financial toxicity as a key challenge for patients undergoing treatment. Research highlights implications for healthcare systems through expenditure patterns and drug pricing.
Topic Hierarchy
Research Sub-Topics
Financial Toxicity in Cancer Patients
This sub-topic examines the financial distress and hardship experienced by cancer patients due to high treatment costs, including out-of-pocket expenses and debt accumulation. Researchers study its prevalence, risk factors, and impacts on treatment adherence and quality of life.
Out-of-Pocket Costs of Cancer Treatment
This sub-topic analyzes direct patient payments for cancer therapies, variations across healthcare systems, and their association with care delays. Researchers investigate cost-sharing mechanisms and policy impacts on patient finances.
Healthcare Expenditure on Cancer Care
This sub-topic focuses on macroeconomic analyses of national and global spending on cancer diagnosis, treatment, and survivorship. Researchers model expenditure trends, drivers like new therapies, and projections for healthcare systems.
Cost Communication in Oncology
This sub-topic explores strategies for discussing treatment costs between clinicians and patients, including tools and training for effective dialogue. Researchers evaluate impacts on decision-making and patient satisfaction.
Productivity Costs of Cancer
This sub-topic assesses indirect economic losses from cancer, such as work absenteeism, reduced productivity, and premature mortality. Researchers develop valuation methods and analyze effects on patients, caregivers, and economies.
Why It Matters
The economic and financial impacts of cancer affect patients through out-of-pocket costs and financial hardship, influencing treatment adherence and quality of life. Healthcare systems face substantial expenditure pressures from rising cancer treatment expenses. For instance, Siegel et al. (2020) in "Cancer statistics, 2020" estimated new cancer cases and deaths in the United States, underscoring the scale of healthcare resource demands implied by incidence data collected through 2016 by the Surveillance, Epidemiology, and End Results Program. Similarly, Bray et al. (2018) in "Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries" provided GLOBOCAN 2018 estimates across 185 countries, highlighting geographic variability in cancer burden that drives global healthcare costs.
Reading Guide
Where to Start
"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries" by Bray et al. (2018), as it provides foundational global incidence and mortality data essential for understanding the scale of economic burdens.
Key Papers Explained
Bray et al. (2018) in "Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries" establishes worldwide cancer burden estimates, which Siegel et al. (2020) in "Cancer statistics, 2020" refines for the U.S. with updated incidence through 2016. Siegel et al. (2019) in "Cancer statistics, 2019" builds on prior years by incorporating survival data through 2015. Siegel et al. (2022) in "Cancer statistics, 2022" extends this series with data through 2018, showing progressive refinements in national statistics.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current work continues annual updates to cancer incidence and mortality estimates, as seen in the progression from Siegel et al. (2013) to Siegel et al. (2022). Focus remains on quantifying burdens to inform cost analyses, with no recent preprints available.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Global cancer statistics 2018: GLOBOCAN estimates of incidence... | 2018 | CA A Cancer Journal fo... | 86.5K | ✓ |
| 2 | Cancer statistics, 2020 | 2020 | CA A Cancer Journal fo... | 21.0K | ✓ |
| 3 | Cancer statistics, 2019 | 2019 | CA A Cancer Journal fo... | 20.7K | ✓ |
| 4 | Cancer statistics, 2022 | 2022 | CA A Cancer Journal fo... | 17.8K | ✓ |
| 5 | The National Comprehensive Cancer Network | 1998 | Cancer | 16.9K | ✕ |
| 6 | Cancer statistics, 2018 | 2018 | CA A Cancer Journal fo... | 16.8K | ✓ |
| 7 | Cancer statistics, 2016 | 2016 | CA A Cancer Journal fo... | 16.1K | ✓ |
| 8 | Cancer statistics, 2017 | 2017 | CA A Cancer Journal fo... | 14.9K | ✓ |
| 9 | Cancer statistics, 2015 | 2015 | CA A Cancer Journal fo... | 11.9K | ✓ |
| 10 | Cancer statistics, 2013 | 2013 | CA A Cancer Journal fo... | 11.9K | ✓ |
Frequently Asked Questions
What is financial toxicity in the context of cancer?
Financial toxicity describes the financial hardship and burden experienced by cancer patients due to high treatment costs. It includes out-of-pocket expenses and lost productivity. This concept captures the economic distress parallel to physical toxicity from treatments.
How do out-of-pocket costs affect cancer patients?
Out-of-pocket costs represent direct payments by patients for cancer care, contributing to financial hardship. These expenses can lead to debt, reduced treatment adherence, and worse health outcomes. Studies in this field quantify their role in overall medical financial burden.
What role does drug pricing play in cancer economics?
Drug pricing influences the total cost of cancer treatment and healthcare expenditure. High prices contribute to elevated out-of-pocket costs and system-wide financial strain. Research examines pricing strategies and their impact on patient access.
How is the scale of cancer's economic impact measured?
The scale is measured through estimates of cancer incidence, mortality, and associated costs like healthcare expenditure. Siegel et al. (2020) in "Cancer statistics, 2020" compiled U.S. data on new cases and deaths. Bray et al. (2018) in "Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries" provided worldwide estimates for 36 cancers across 185 countries.
What are productivity costs in cancer economics?
Productivity costs account for lost work time and income due to cancer treatment and morbidity. These indirect costs add to the total economic burden beyond direct medical expenses. They affect patients, families, and economies through reduced labor output.
Why is cost communication important in cancer care?
Cost communication involves discussing treatment expenses with patients to mitigate financial toxicity. It enables informed decisions on care options and financial planning. Effective communication reduces surprises from out-of-pocket costs.
Open Research Questions
- ? How do variations in out-of-pocket costs across countries influence cancer treatment adherence and survival rates?
- ? What productivity cost models best capture indirect economic losses from cancer in low-income populations?
- ? To what extent does drug pricing transparency reduce overall healthcare expenditure on cancer?
- ? How do financial toxicity interventions impact long-term patient debt and healthcare system sustainability?
- ? What geographic factors drive disparities in cancer-related financial hardship worldwide?
Recent Trends
The field includes 37,112 works with sustained high citation of annual cancer statistics papers, such as "Cancer statistics, 2022" by Siegel et al. at 17,802 citations.
2022Updates from 2013 (11,877 citations) to 2022 reflect ongoing refinement of U.S. incidence data.
Global estimates in Bray et al. at 86,450 citations anchor international comparisons.
2018Research Economic and Financial Impacts of Cancer with AI
PapersFlow provides specialized AI tools for Economics, Econometrics and Finance researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Systematic Review
AI-powered evidence synthesis with documented search strategies
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Economics & Business use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Economic and Financial Impacts of Cancer with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Economics, Econometrics and Finance researchers